RELT/TNFRSF19L Antibody (238104)

Raji human Burkitt's lymphoma cell line was stained with Mouse Anti-Human RELT/TNFRSF19L Monoclonal Antibody (Catalog # MAB1385, filled histogram) or isotype control antibody (Catalog # MAB0041, open histogram), followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0102B).

• Reactivity: Hu
• Applications: Flow, CyTOF-ready
• Clone: 238104
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Concentration: LYOPH

RELT/TNFRSF19L Antibody (238104) Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant human RELT/TNFRSF19L
  Met1-Ala160 (Arg127Gly, Arg129Gly)
  Accession # Q969Z4
• Specificity: Detects human RELT/TNFRSF19L in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) 4-1BB, recombinant mouse (rm) 4-1BB, rhBAFF R, rmBAFF R, rhCD27, rmCD27, rhCD30, rmCD30, rhCD40, rmCD40, rhDR3, rmDR3, rhDR6, rhEDAR, rmEDAR, rhFas, rmFas, rrFas, rhGITR, rmGITR, rhHVEM, rhLT beta R, rmLT beta R, rhNGF R, rmNGF R, rhOPG, rmOPG, rmOX40, rhRANK, rmRANK, rhTNF RI, rmTNF RI, rhTNF RII, rmTNF RII, rhTRAIL R1, rhTRAIL R2, rhTRAIL R3, rhTRAIL R4, rhTROY, or rmTROY is observed.
• Source: N/A
• Isotype: IgG2b
• Clonality: Monoclonal
• Host: Mouse
• Gene: RELT
• Purity Statement: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Dilutions:
  • CyTOF-ready
  • Flow Cytometry 0.25 ug/10^6 cells

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
• Preservative: No Preservative
• Concentration: LYOPH
• Reconstitution Instructions: Reconstitute at 0.5 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for RELT/TNFRSF19L Antibody (238104)

• Receptor expressed in lymphoid tissues
• RELT tumor necrosis factor receptor
• RELT
• TNFRSF19L
• TNFRSF19LFLJ14993
• tumor necrosis factor receptor superfamily member 19L
• tumor necrosis factor receptor superfamily, member 19-like

Background

RELT (Receptor Expressed in Lymphoid Tissues) is a type I transmembrane glycoprotein belonging to the tumor necrosis factor receptor superfamily (TNFRSF) and has been designated TNFRSF19-like (TNFRSF19L) (1, 2). It is primarily expressed in hematopoietic tissues and peripheral blood leukocytes. Human RELT cDNA encodes a 430 amino acid (aa) residue precursor protein with a putative 26 aa signal peptide, a 136 aa extracellular domain containing one TNF receptor cysteine-rich domain and one potential N-linked glycosylation site, a 21 aa transmembrane domain and a 247 aa cytoplasmic region containing no death domain. Human RELT shares 85% and 96% aa sequence homology with mouse RELT (Accession # BAC40459) and macaque RELT (Accession # Q9N092), respectively. Among TNFRSF members, the RELT extracellular domain is most closely related to that of TNFRSF19 and OX40. RELT has been shown to exclusively bind the adaptor protein TNF receptor-associated factor 1 (TRAF1). However, it has also been shown to activate the NF-kappa B pathway independently of TRAFs. Immobilized RELT can co‑stimulate T‑cell proliferation in the presence of CD3 signaling, suggesting a potential regulatory role in immune response.

1. http://www.gene.ucl.ac.uk/nomenclature/genefamily/tnftop.html.
2. Sica, G. et al. (2001) Blood 97:2702.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: RELT
• Uniprot:
  • Q969Z4()